
Pacs (PACS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2024Income Metrics
Revenue
981.8M
Gross Profit
153.9M
15.67%
Operating Income
710.0K
0.07%
Net Income
-10.9M
-1.11%
EPS (Diluted)
$-0.07
Balance Sheet Metrics
Total Assets
3.9B
Total Liabilities
3.3B
Shareholders Equity
578.2M
Debt to Equity
5.74
Cash Flow Metrics
Operating Cash Flow
-33.5M
Free Cash Flow
-76.7M
Revenue & Profitability Trend
Pacs Income Statement From 2021 to 2023
Metric | 2023 | 2022 | 2021 |
---|---|---|---|
Revenue | 3.1B | 2.4B | 1.2B |
Cost of Goods Sold | 2.7B | 2.0B | 979.2M |
Gross Profit | 447.1M | 400.7M | 187.3M |
Gross Margin % | 14.4% | 16.5% | 16.1% |
Operating Expenses | |||
Research & Development | - | - | - |
Selling, General & Administrative | 213.7M | 149.0M | 96.8M |
Other Operating Expenses | - | - | - |
Total Operating Expenses | 213.7M | 149.0M | 96.8M |
Operating Income | 207.8M | 229.4M | 83.4M |
Operating Margin % | 6.7% | 9.5% | 7.1% |
Non-Operating Items | |||
Interest Income | - | - | - |
Interest Expense | 49.9M | 25.5M | 5.3M |
Other Non-Operating Income | -536.0K | 3.2M | 3.3M |
Pre-tax Income | 157.3M | 207.0M | 81.4M |
Income Tax | 44.4M | 56.5M | 33.5M |
Effective Tax Rate % | 28.2% | 27.3% | 41.1% |
Net Income | 112.9M | 150.5M | 47.9M |
Net Margin % | 3.6% | 6.2% | 4.1% |
Key Metrics | |||
EBITDA | 232.9M | 254.9M | 93.9M |
EPS (Basic) | $0.75 | $1.00 | $0.32 |
EPS (Diluted) | $0.75 | $1.00 | $0.32 |
Basic Shares Outstanding | 150151958 | 150151958 | 150151958 |
Diluted Shares Outstanding | 150151958 | 150151958 | 150151958 |
Income Statement Trend
Pacs Balance Sheet From 2022 to 2023
Metric | 2023 | 2022 |
---|---|---|
Assets | ||
Current Assets | ||
Cash & Equivalents | 73.4M | 58.3M |
Short-term Investments | - | - |
Accounts Receivable | 547.8M | 370.9M |
Inventory | - | - |
Other Current Assets | 48.7M | 32.8M |
Total Current Assets | 722.1M | 511.2M |
Non-Current Assets | ||
Property, Plant & Equipment | 2.0B | 1.4B |
Goodwill | 124.3M | 116.7M |
Intangible Assets | 6.3M | 6.3M |
Long-term Investments | - | - |
Other Non-Current Assets | 140.0M | 113.6M |
Total Non-Current Assets | 2.8B | 2.0B |
Total Assets | 3.5B | 2.5B |
Liabilities | ||
Current Liabilities | ||
Accounts Payable | 140.9M | 110.6M |
Short-term Debt | 127.2M | 182.4M |
Current Portion of Long-term Debt | - | - |
Other Current Liabilities | - | - |
Total Current Liabilities | 456.9M | 483.9M |
Non-Current Liabilities | ||
Long-term Debt | 2.7B | 1.7B |
Deferred Tax Liabilities | - | - |
Other Non-Current Liabilities | 123.5M | 37.1M |
Total Non-Current Liabilities | 3.0B | 1.9B |
Total Liabilities | 3.4B | 2.4B |
Equity | ||
Common Stock | 129.0K | 129.0K |
Retained Earnings | 96.0M | 63.5M |
Treasury Stock | - | - |
Other Equity | - | - |
Total Shareholders Equity | 101.7M | 68.7M |
Key Metrics | ||
Total Debt | 2.8B | 1.9B |
Working Capital | 265.2M | 27.3M |
Balance Sheet Composition
Pacs Cash Flow Statement From 2021 to 2023
Metric | 2023 | 2022 | 2021 |
---|---|---|---|
Operating Activities | |||
Net Income | 112.9M | 150.5M | 47.9M |
Depreciation & Amortization | 25.6M | 22.3M | 7.2M |
Stock-Based Compensation | - | - | - |
Working Capital Changes | -62.3M | -125.6M | -33.5M |
Operating Cash Flow | 95.1M | 61.0M | 31.7M |
Investing Activities | |||
Capital Expenditures | -172.8M | -78.2M | -203.8M |
Acquisitions | -2.6M | 0 | -15.7M |
Investment Purchases | - | - | - |
Investment Sales | - | - | - |
Investing Cash Flow | -174.7M | -78.2M | -219.5M |
Financing Activities | |||
Share Repurchases | - | - | - |
Dividends Paid | -80.4M | -60.3M | -53.8M |
Debt Issuance | 1.3B | 242.4M | 622.4M |
Debt Repayment | -1.1B | -173.0M | -386.6M |
Financing Cash Flow | 129.6M | 12.4M | 182.0M |
Free Cash Flow | -109.1M | 14.4M | -146.2M |
Net Change in Cash | 50.0M | -4.9M | -5.8M |
Cash Flow Trend
Pacs Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
19.41
Forward P/E
6.61
Price to Book
3.15
Price to Sales
0.52
PEG Ratio
6.61
Profitability Ratios
Profit Margin
2.59%
Operating Margin
0.07%
Return on Equity
110.96%
Return on Assets
3.21%
Financial Health
Current Ratio
1.71
Debt to Equity
469.36
Per Share Data
EPS (TTM)
$0.61
Book Value per Share
$3.75
Revenue per Share
$26.58
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
pacs | 1.8B | 19.41 | 3.15 | 110.96% | 2.59% | 469.36 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 1.9B | 13.80 | 0.62 | 4.83% | 4.31% | 74.74 |
Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
Ardent Health | 1.8B | 6.57 | 1.44 | 24.32% | 4.11% | 138.17 |
Financial data is updated regularly. All figures are in the company's reporting currency.